ArticleJournal of oncology2009

Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer.

Helenia Ansuini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.